Target intelligence / Profile preview

Protein O-glucosyltransferase 1 (POGLUT1)

Target
POGLUT1
Molecular classification
Enzyme, Glycosyltransferase (specifically, an inverting GT-B fold glycosyltransferase, CAZy GT Family 90)
01

Overview

Protein O-glucosyltransferase 1 (POGLUT1) is an enzyme localized in the endoplasmic reticulum that catalyzes the transfer of glucose (and, to a lesser extent, xylose) to serine residues within specific consensus sequences of EGF-like repeats in multiple substrate proteins, especially Notch receptors[1][2][3][4][5][7]. Through this posttranslational modification, POGLUT1 is essential for proper Notch receptor folding and function, thereby enabling activation of the Notch signaling pathway, which is crucial for cellular differentiation, proliferation, and apoptosis throughout development and adult life[3][7]. Mutations or dysregulation of POGLUT1 are implicated in genetic disorders such as limb-girdle muscular dystrophy type 21 (LGMDR21) and Dowling-Degos disease, highlighting its pivotal role in both muscular and dermatologic tissue biology[3][6]. POGLUT1 belongs to the CAP10-like family of glycosyltransferases and shares structural and functional homology with its Drosophila homolog, Rumi[5][6].

Other names
C3orf9CLP46KTELC1KDELCL1MDSRPMDS010UNQ490/PRO1006hCLP46hRumiMGC329959630046K23RikRumiCAP10-like 46 kDa proteinKTEL motif-containing protein 1Myelodysplastic syndromes relative proteinProtein O-xylosyltransferase POGLUT1KDELC family like 1LGMD2ZLGMDR21
02

Mechanism of action

Enzyme inhibition (theoretical, for any future inhibitors targeting Notch signaling regulation via POGLUT1 modulation)

03

Biological functions

Posttranslational modification (O-glucosylation and O-xylosylation of epidermal growth factor (EGF)-like domains)Regulation of Notch signaling pathwayCell specialization (cell fate determination)Cell proliferationCell differentiationApoptosis (programmed cell death)Protein processing in the endoplasmic reticulum
04

Disease associations

Cancer (by Notch pathway dysregulation, implicated in some cancers)Muscular dystrophy (specifically limb-girdle muscular dystrophy, autosomal recessive 21, LGMDR21)Dowling-Degos disease (Dowling-Degos disease 4, a pigmentary skin disorder)Other developmental disorders linked to abnormal Notch signaling
05

Safety considerations

Disruption of Notch signaling can affect multiple organ systems, given its role in development, differentiation, and cell fatePotential for carcinogenesis or developmental defects if broadly inhibited or dysregulated
06

Biomarkers

POGLUT1 gene/protein expression (potentially for limb-girdle muscular dystrophy, Dowling-Degos disease diagnostics)

Beyond the preview

Go deeper on Protein O-glucosyltransferase 1 (POGLUT1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Protein O-glucosyltransferase 1 (POGLUT1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call